Zhengye Biotechnology Holding (ZYBT) Long-Term Investments (2023 - 2025)

Zhengye Biotechnology Holding has reported Long-Term Investments over the past 3 years, most recently at $30.5 million for Q4 2025.

  • Quarterly Long-Term Investments fell 22.77% to $30.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $30.5 million through Dec 2025, down 22.77% year-over-year, with the annual reading at $31.0 million for FY2025, 20.42% down from the prior year.
  • Long-Term Investments was $30.5 million for Q4 2025 at Zhengye Biotechnology Holding, down from $39.5 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $39.5 million in Q4 2024 and troughed at $30.5 million in Q4 2025.
  • The 3-year median for Long-Term Investments is $37.9 million (2023), against an average of $36.0 million.
  • Year-over-year, Long-Term Investments increased 4.32% in 2024 and then fell 22.77% in 2025.
  • A 3-year view of Long-Term Investments shows it stood at $37.9 million in 2023, then grew by 4.32% to $39.5 million in 2024, then decreased by 22.77% to $30.5 million in 2025.
  • Per Business Quant, the three most recent readings for ZYBT's Long-Term Investments are $30.5 million (Q4 2025), $39.5 million (Q4 2024), and $37.9 million (Q4 2023).